A simple preparation method for mouse eosinophils and their responses to anti-allergic drugs

Inflammation Research

Volumn 56, Issue 3, 2007, Pages 112-117

  Ebihara, S ^a   Kurachi, H ^a   Watanabe, Y ^a  

^a JAPAN TOBACCO INC   (Japan)

Author keywords

Anti allergic drug; Drug screening; IL 5; LTC4; Mouse eosinophil

Indexed keywords

ANTIALLERGIC AGENT; INTERLEUKIN 5; LEUKOTRIENE C4; OVALBUMIN; OXATOMIDE; THROMBOCYTE ACTIVATING FACTOR; TRANILAST;

ALLERGIC REACTION; ANIMAL EXPERIMENT; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG INHIBITION; DRUG SCREENING; EOSINOPHIL; FEMALE; MOUSE; NONHUMAN; PERITONEUM EXUDATE; PHENOTYPE;

ANIMALS; ANTI-ALLERGIC AGENTS; CELL MOVEMENT; CELL SEPARATION; CHEMOKINES, CC; EOSINOPHILS; FEMALE; INTERLEUKIN-5; LEUKOTRIENE C4; MICE; MICE, INBRED BALB C; OVALBUMIN; PHENOTYPE; PLATELET ACTIVATING FACTOR; RANTES;

EID: 34147175385     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-006-6063-5     Document Type: Article

References (38)

1. Rothenberg ME, Hogan SP. The Eosinophil. Annu Rev Immunol 2005; 24: 5.1-5.28.
2. Simon D, Braathen LR, Simon HU. Eosinophils and atopic dermatitis. Allergy 2004; 59: 561-70.
3. Shen HH, Ochkur SI, McGarry MP, Crosby JR, Hines EM, Borchers MT et al. A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies in the mouse. J Immunol 2003; 170: 3296-305.
4. Lee JJ, Dimina D, Macias MP, Ochkur SI, McGarry MP, O'Neill KR et al. Defining a link with asthma in mice congenitally deficient in eosinophils. Science 2004; 305: 1773-6.
5. Humbles AA, Lloyd CM, McMillan SJ, Friend DS, Xanthou G, McKenna EE et al. A critical role for eosinophils in allergic airways remodeling. Science 2004; 305: 1776-9.
6. Davis MD, Plager DA, George TJ, Weiss EA, Gleich GJ, Leiferman KM. Interactions of eosinophil granule proteins with skin: limits of detection, persistence, and vasopermeabilization. J Allergy Clin Immunol 2003; 112: 988-94.
7. Watanabe Y, Hashizume M, Kataoka S, Hamaguchi E, Morimoto N, Tsuru S et al. Differentiation stages of eosinophils characterized by hyaluronic acid binding via CD44 and responsiveness to stimuli. DNA Cell Biol 2001; 20: 189-202.
8. Dent LA, Munro GH, Piper KP, Sanderson CJ, Finlay DA, Dempster RK et al. Eosinophilic interleukin 5 (IL-5) transgenic mice: eosinophil activity and impaired clearance of Schistosoma mansoni. Parasite Immunol 1997; 19: 291-300.
9. Ganzalo JA, Jia GQ, Aguirre V, Friend D, Coyle AJ, Jenkins NA et al. Mouse Eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response. Immunity 1996; 4:1-14.
10. Rothenberg ME, Ownbey R, Mehlhop PD, Loiselle PM, van de Rijn M, Bonventre JV et al. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice. Mol Med 1996; 2: 334-48.
11. Jia GQ, Gonzalo JA, Hidalgo A, Wagner D, Cybulsky M, Gutierrez-Ramos JC. Selective eosinophil transendothelial migration triggered by eotaxin via modulation of Mac-1/ICAM-1 and VLA-4/VCAM-1 interactions. Int Immunol 1999; 11: 1-10.
12. Borchers MT, Ansay T, DeSalle R, Daugherty BL, Shen H, Metzger M et al. In vitro assessment of chemokine receptor-ligand interactions mediating mouse eosinophil migration. J Leukoc Biol 2002; 71: 1033-41.
13. Kobayashi T, Iijima K, Kita H. Marked airway eosinophilia prevents development of airway hyper-responsiveness during an allergic response in IL-5 transgenic mice. J Immunol 2003; 170: 5756-63.
14. Panzenhagen H, Speirs R. Effect of horse serum, adrenal hormones, and histamine on the number of eosinophils in the blood and peritoneal fluid of mice. Blood 1953; 8: 536-44.
15. Oliveira SH, Costa CH, Ferreira SH, Cunha FQ. Sephadex induces eosinophil migration to the rat and mouse peritoneal cavity: involvement of mast cells, LTB4, TNF-alpha, IL-8 and PAF. Inflamm Res 2002; 51: 144-53.
16. Kumar RK, Foster PS. Modeling allergic asthma in mice: pitfalls and opportunities. Am J Respir Cell Mol Biol 2002; 27: 267-72.
17. Lopez E, del Pozo V, Miguel T, Sastre B, Seoane C, Civantos E et al. Inhibition of chronic airway inflammation and remodeling by galectin-3 gene therapy in a murine model. J Immunol 2006; 176: 1943-50.
18. + T lymphocyte and eosinophil infiltration into the mouse peritoneal cavity. J Immunol 1996; 157: 377-84.
19. Oliveira SH, Taub DD, Nagel J, Smith R, Hogaboam CM, Berlin A et al. Stem cell factor induces eosinophil activation and degranulation: mediator release and gene array analysis. Blood 2002; 100: 4291-7.
20. Jones RE, Finkelman FD, Hester RB, Kayes SG. Toxocara canis: failure to find IgE receptors (FcεR) on eosinophils from infected mice suggests that murine eosinophils do not kill helminth larvae by an IgE-dependent mechanism. Exp Parasitol 1994; 78: 64-75.
21. de Andres B, Cardaba B, del Pozo V, Martin-Orozco E, Gallardo S, Tramon P et al. Modulation of the FcγRII and FcγRIII induced by GM-CSF, IFN-γ and IL-4 on murine eosinophils. Immunology 1994; 83: 155-60.
22. de Andres B, Rakasz E, Hagen M, McCormik ML, Mueller AL, Elliot D et al. Lack of Fc-ε receptors on murine eosinophils: implications for the functional significance of elevated IgE and eosinophils in parasitic infections. Blood 1997; 89: 3826-36.
23. Kita H, Kaneko M, Bartemes KR, Weiler DA, Schimming AW, Reed CE, et al. Does IgE bind to and activate eosinophils from patients with allergy? J Immunol 1999; 162: 6901-11.
24. Davoine F, Labonte I, Ferland C, Mazer B, Chakir J, Laviolette M. Role and modulation of CD16 expression on eosinophils by cytokines and immune complexes. Int Arch Allergy Immunol 2004; 134: 165-72.
25. Pinho V, Oliveira SH, Souza DG, Vasconcelos D, Alessandri AL, Lukacs NW et al. The role of CCL22 (MDC) for the recruitment of eosinophils during allergic pleurisy in mice. J Leukoc Biol 2003; 73: 356-62.
26. Patella V, de Crescenzo G, Marino O, Spadaro G, Genovese A, Marone G. Oxatomide inhibits the release of proinflammatory mediators from human basophils and mast cells. Int Arch Allergy Immunol 1996; 111: 23-9.
27. Zampini P, Riviera AP, Tridente G. In vitro inhibition of histamine release from mouse mast cells and human basophils by an anthranilic acid derivative. Int J Immunopharmacol 1983; 5: 431-5.
28. Kishida M, Sasamoto A, Saito S, Iikura Y. Oxatomide modifies methacholine- and exercise-induced bronchoconstriction in asthmatic children. Ann Allergy 1992; 69: 455-61.
29. Hoshino K, Kawasaki A, Mizushima Y, Yano S. Effect of antiallergic agents and bronchial hypersensitivity in short-term bronchial asthma. Chest 1991; 100: 57-62.
30. Manabe H, Ohmori K, Tomioka H, Yoshida S. Oxatomide inhibits the release of chemical mediators from human lung tissues and from granulocytes. Int Arch Allergy Appl Immunol 1988; 87: 91-7.
31. 4 by murine eosinophils: role of intra- and extracellular calcium. Immunology 1990; 69: 271-6.
32. Homey B, Zlotnik A. Chemokines in allergy. Curr Opin Immunol 1999; 11: 626-34.
33. Teixeira MM, Wells TN, Lukacs NW, Proudfoot AE, Kunkel SL, Williams TJ et al. Chemokine-induced Eosinophil Recruitment. Evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin. J Clin Invest 1997; 100: 1657-66.
34. Kameyoshi Y, Dorschner A, Mallet AI, Christophers E, Schroder JM. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med 1992; 176: 587-92.
35. Bandeira-Melo C, Weller PF. Eosinophils and cysteinyl leukotrienes. Prostaglandins Leukot Essent Fatty Acids 2003; 69: 135-43.
36. Wenzel SE. The role of leukotrienes in asthma. Prostaglandins Leukot Essent Fatty Acids. 2003; 69: 145-55.
37. Bartemes KR, McKinney S, Gleich GJ, Kita H. Endogenous platelet-activating factor is critically involved in effector functions of eosinophils stimulated with IL-5 or IgG. J Immunol 1999; 162: 2982-9.
38. Hamelmann E, Gelfand EW. IL-5-induced airway eosinophilia-the key to asthma? Immunol Rev 2001; 179: 182-91.